Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
FDA approves computer-aided detection on digital mammography system
May 13th, 2004
Hologic, Inc., (HOLX) and R2 Technology, Inc., announced that R2 has received U.S. Food and Drug Administration (FDA) approval for the use of R2's ImageChecker CAD technology customized for Hologic's Selenia full field digital mammography (FFDM) system. CAD technology has the potential to detect findings that might otherwise be overlooked during the review process, thus increasing cancer detection. CAD technology also is especially effective in identifying calcifications, some of which can be cancerous. "Receiving FDA approval finalizes the commitment of both companies to merge our premier technologies together in a package that we believe will...
Source: Women's Health Weekly (2004-05-13)
|
